Sustained spinal cord compression - Part II: Effect of methylprednisolone on regional blood flow and recovery of somatosensory evoked potentials

被引:24
作者
Carlson, GD
Gorden, CD
Nakazawa, S
Wada, E
Smith, JS
LaManna, JC
机构
[1] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Univ Hosp Spine Inst, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Anat & Neurol, Cleveland, OH 44106 USA
关键词
D O I
10.2106/00004623-200301000-00015
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The efficacy of methylprednisolone in the treatment of traumatic spinal cord injury is controversial. We examined the effect of methylprednisolone on regional spinal cord blood flow and attempted to determine whether recovery of electrophysiological function is dependent on reperfusion, either during sustained spinal cord compression or after decompression. Methods: The effects of methylprednisolone therapy on recovery of somatosensory evoked potentials and on spinal cord blood flow were examined in a canine model of dynamic spinal cord compression. Methylprednisolone (30 mg/kg intravenous loading dose followed by 5.4 mg/kg/hr intravenous infusion) or saline solution was administered to thirty-six beagles (eighteen in each group) five minutes after cessation of dynamic spinal cord compression and loss of all somatosensory evoked potentials. After ninety minutes of sustained compression, the spinal cords were decompressed. Somatosensory evoked potentials and spinal cord blood flow were evaluated throughout the period of sustained compression and for three hours after decompression. Results: Seven dogs treated with methylprednisolone and none treated with saline solution recovered measurable somatosensory evoked potentials during sustained compression. After decompression, three more dogs treated with methylprednisolone and seven dogs treated with saline solution recovered somatosensory evoked potentials. Four dogs treated with methylprednisolone lost their previously measurable somatosensory evoked potentials. In the methylprednisolone group, spinal cord blood flow was significantly higher (p < 0.05) in the dogs that had recovered somatosensory evoked potentials than it was in the dogs that had not. Reperfusion blood flow was significantly higher (p < 0.05) in the saline-solution group than it was in the methylprednisolone group. Spinal cord blood flow in the saline-solution group returned to baseline levels within five minutes after decompression. It did not return to baseline levels in the dogs treated with methylprednisolone. Conclusions: The methylprednisolone administered in this study did not provide a large or significant lasting benefit with regard to neurological preservation or restoration. Methylprednisolone may reduce regional spinal cord blood flow through mechanisms affecting normal autoregulatory blood-flow function. Clinical Relevance: This study suggests that a major drawback of methylprednisolone therapy may be the reduction in regional spinal cord blood flow after decompression.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 27 条
[1]  
AKI T, 1984, SPINE, V9, P800, DOI 10.1097/00007632-198411000-00006
[2]   Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury [J].
Amar, AP ;
Levy, ML .
NEUROSURGERY, 1999, 44 (05) :1027-1039
[3]  
Bracken MB, 2000, J NEUROSURG, V93, P340
[4]   EFFECTS OF TIMING OF METHYLPREDNISOLONE OR NALOXONE ADMINISTRATION ON RECOVERY OF SEGMENTAL AND LONG-TRACT NEUROLOGICAL FUNCTION IN NASCIS-2 [J].
BRACKEN, MB ;
HOLFORD, TR .
JOURNAL OF NEUROSURGERY, 1993, 79 (04) :500-507
[5]   A RANDOMIZED, CONTROLLED TRIAL OF METHYLPREDNISOLONE OR NALOXONE IN THE TREATMENT OF ACUTE SPINAL-CORD INJURY - RESULTS OF THE 2ND NATIONAL ACUTE SPINAL-CORD INJURY STUDY [J].
BRACKEN, MB ;
SHEPARD, MJ ;
COLLINS, WF ;
HOLFORD, TR ;
YOUNG, W ;
BASKIN, DS ;
EISENBERG, HM ;
FLAMM, E ;
LEOSUMMERS, L ;
MAROON, J ;
MARSHALL, LF ;
PEROT, PL ;
PIEPMEIER, J ;
SONNTAG, VKH ;
WAGNER, FC ;
WILBERGER, JE ;
WINN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) :1405-1411
[6]   Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up - Results of the third National Acute Spinal Cord Injury randomized controlled trial [J].
Bracken, MB ;
Shepard, MJ ;
Holford, TR ;
Leo-Summers, L ;
Aldrich, EF ;
Fazl, M ;
Fehlings, MG ;
Herr, DL ;
Hitchon, PW ;
Marshall, LF ;
Nockels, RP ;
Pascale, V ;
Perot, PL ;
Piepmeier, J ;
Sonntag, VKH ;
Wagner, F ;
Wilberger, JE ;
Winn, HR ;
Young, W .
JOURNAL OF NEUROSURGERY, 1998, 89 (05) :699-706
[7]   Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury - Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial [J].
Bracken, MB ;
Shepard, MJ ;
Holford, TR ;
LeoSummers, L ;
Aldrich, EF ;
Fazl, M ;
Fehlings, M ;
Herr, DL ;
Hitchon, PW ;
Marshall, LF ;
Nockels, RP ;
Pascale, V ;
Perot, PL ;
Piepmeier, J ;
Sonntag, VKH ;
Wagner, F ;
Wilberger, JE ;
Winn, HR ;
Young, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (20) :1597-1604
[8]  
BRAUGHLER JM, 1983, J NEUROSURG, V58, P538
[9]   Viscoelastic relaxation and regional blood flow response to spinal cord compression and decompression [J].
Carlson, GD ;
Warden, KE ;
Barbeau, JM ;
Bahniuk, E ;
KutinaNelson, KL ;
Biro, CL ;
Bohlman, HH ;
LaManna, JC .
SPINE, 1997, 22 (12) :1285-1291
[10]   Perfusion-limited recovery of evoked potential function after spinal cord injury [J].
Carlson, GD ;
Gorden, CD ;
Nakazowa, S ;
Wada, E ;
Warden, K ;
LaManna, JC .
SPINE, 2000, 25 (10) :1218-1226